pre-pectoral breast implant
Showing 1 - 25 of >10,000
Genetic Predisposition, Breast Cancer Trial in Montpellier (Prophylactic mastectomy with immediate breast reconstruction)
Recruiting
- Genetic Predisposition
- Breast Cancer
- Prophylactic mastectomy with immediate breast reconstruction
-
Montpellier, Hérault, FranceMontpellier University Hospital
Dec 9, 2022
AlloMend® Acellular Dermal Matrix Used in Breast Implant
Not yet recruiting
- Breast Implant; Complications, Infection or Inflammation
-
Reno, NevadaJaniga MDs Plastic Surgery and Cosmetic Center
Feb 15, 2023
Breast Cancer, Breast Implant; Complications, Infection or Inflammation Trial (Acellular Dermal Matrix, Reconstruction without
Not yet recruiting
- Breast Cancer
- Breast Implant; Complications, Infection or Inflammation
- Acellular Dermal Matrix
- Reconstruction without ADM
- (no location specified)
Jan 4, 2022
Postoperative Pain, Postoperative Nausea and Vomiting, Quality of Life Trial in Baltimore (Pre-pectoral Tissue Expander)
Completed
- Postoperative Pain
- +4 more
- Pre-pectoral Tissue Expander
-
Baltimore, MarylandThe Johns Hopkins University
Dec 15, 2021
Breast Reconstruction, Implant-Based Breast Reconstruction (IBBR) Trial in Worldwide (pre-pectoral IBBR, sub-pectoral IBBR)
Recruiting
- Breast Reconstruction
- Implant-Based Breast Reconstruction (IBBR)
- pre-pectoral IBBR
- sub-pectoral IBBR
-
Boston, Massachusetts
- +24 more
Nov 1, 2021
International Prospective REgistry on Pre-pectorAl Breast
Not yet recruiting
- Breast Cancer
- pre-pectoral breast reconstruction
- (no location specified)
Apr 4, 2023
Measures Using BREAST-Q Questionnaire in Patients Undergoing Pre
Recruiting
- Breast Disease
- +3 more
- Pre- or sub-pectoral implant based immediate breast reconstruction
-
Leeds, West Yorkshire, United KingdomLeeds Teaching Hospitals NHS Trust
Apr 8, 2021
Prepectoral Breast Reconstruction, TiLOOP Mesh Trial (prepectoral breast reconstruction, Tiloop Mesh implantation)
Not yet recruiting
- Prepectoral Breast Reconstruction
- TiLOOP Mesh
- prepectoral breast reconstruction
- Tiloop Mesh implantation
- (no location specified)
Jun 9, 2023
Euromi Biosciences Pre-filled Silicone Gel Breast Implants
Not yet recruiting
- Breast Implant Rupture
- Breast Implant; Complications
- Breast reconstruction
-
Nancy, FranceCHRU Nancy
Aug 10, 2023
Breast Cancer, Risk Reduction Trial in Oxford (Prepectoral implant-based immediate breast reconstruction)
Enrolling by invitation
- Breast Cancer
- Risk Reduction
- Prepectoral implant-based immediate breast reconstruction
-
Oxford, Oxfordshire, United KingdomSurigcal Intervention Trials Unit (SITU), Nuffield Department of
Oct 30, 2023
Breast Cancer, Radiation, Breast Reconstruction Trial in China, Germany, United States (TiLoop Bra mesh in expander-implant
Recruiting
- Breast Cancer
- +3 more
- TiLoop Bra mesh in expander-implant breast reconstrution
- sub-pectoral expander-implant breast reconstruction
-
Houston, Texas
- +5 more
Jul 19, 2021
Breast Cancer Trial in Netherlands (autologous fat transfer, breast implant)
Active, not recruiting
- Breast Cancer
- autologous fat transfer
- breast implant
-
Amstelveen, Netherlands
- +6 more
Feb 3, 2022
Pain, Postoperative Trial in Lille (Ropivacaine (PECS bloc), Placebo)
Completed
- Pain, Postoperative
- Ropivacaine (PECS bloc)
- Placebo
-
Lille, FranceHôpital Roger Salengro, CHU de Lille
Aug 24, 2020
Breast Reconstruction in Previously Irradiated Breast
Completed
- Mammaplasty
- +3 more
- Pre reconstruction Radiotherapy
-
Rozzano, Milan, ItalyIstituto Clinico Humanitas
Apr 21, 2021
Breast Cancer Trial in China (ZOLADEX 10.8 mg, ZOLADEX 3.6mg)
Withdrawn
- Breast Cancer
- ZOLADEX 10.8 mg
- ZOLADEX 3.6mg
-
Beijing, China
- +10 more
May 6, 2021
Prepectoral and Subpectoral Breast Reconstruction
Recruiting
- Stage II Breast Cancer
- Stage I Breast Cancer
- The breast reconstruction method after single-port insufflation endoscopic nipple-sparing mastectomy
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital medical University
Apr 16, 2023
Mastectomy, Segmental, Breast Tumor Malignant Female Trial in Milan, Pisa, A Coruña (REGENERA breast implant implantation)
Not yet recruiting
- Mastectomy, Segmental
- Breast Neoplasm Malignant Female
- REGENERA breast implant implantation
-
Milan, Italy
- +2 more
Jul 11, 2023
Post-operative Pain Trial in Sacramento (On-Q, Ultrasound guided pectoral nerve block)
Terminated
- Post-operative Pain
- On-Q
- Ultrasound guided pectoral nerve block
-
Sacramento, CaliforniaUC Davis Medical Center
Oct 14, 2021
Associated With Breast Implant Complications
Recruiting
- Breast Implant; Complications, Infection or Inflammation
-
Carmel, Indiana
- +2 more
Feb 16, 2023
Breast Reconstruction Following Mastectomy Trial in Weston (Prepectoral approach, Partial Subpectoral approach)
Not yet recruiting
- Breast Reconstruction Following Mastectomy
- Prepectoral approach
- Partial Subpectoral approach
-
Weston, FloridaCleveland Clinic Florida, Case Comprehensive Cancer Center
Jan 30, 2023
Breast Cancer Trial in Milano (skin reducing mastectomy)
Completed
- Breast Cancer
- skin reducing mastectomy
-
Milano, Lombardia, ItalyIstituto Europeo di Oncologia
Nov 10, 2023
Breast Cancer, High Risk of Breast Cancer Trial in Dallas (da Vinci SP Surgical System)
Recruiting
- Breast Cancer
- High Risk of Breast Cancer
- da Vinci SP Surgical System
-
Dallas, TexasUT Southwestern
Mar 21, 2022
Mammaplasty, Breast Cancer, Poland Syndrome Trial in Worldwide (Motiva Flora® Tissue Expander)
Recruiting
- Mammaplasty
- +2 more
- Motiva Flora® Tissue Expander
-
Ghent, Belgium
- +3 more
Nov 29, 2023
Breast Cancer, Capsular Contracture Associated With Breast Implant Trial in France (NovaGray RILA Breast® test)
Recruiting
- Breast Cancer
- Capsular Contracture Associated With Breast Implant
- NovaGray RILA Breast® test
-
Lille, France
- +7 more
Jan 6, 2023
Gender Dysphoria, Opioid Use, Pain, Postoperative Trial in San Francisco (Ropivacaine 0.2% Injectable Solution, Saline (0.9%))
Active, not recruiting
- Gender Dysphoria
- +2 more
- Ropivacaine 0.2% Injectable Solution
- Saline (0.9%)
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 13, 2022